Dependence of NPPS creates a targetable vulnerability in RAS-mutant cancers.
Xia RX, Zou PC, Xie JT, Tang YB, Gong MM, Fan F, Aihemaiti A, Liu YQ, Shen Y, Zhou BS, Zhu L, Lei HM.
Xia RX, et al. Among authors: shen y.
Acta Pharmacol Sin. 2024 Nov 6. doi: 10.1038/s41401-024-01409-2. Online ahead of print.
Acta Pharmacol Sin. 2024.
PMID: 39506063